Connection

JONATHAN FLANAGAN to Male

This is a "connection" page, showing publications JONATHAN FLANAGAN has written about Male.
Connection Strength

0.097
  1. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia. Br J Haematol. 2012 Apr; 157(2):240-8.
    View in: PubMed
    Score: 0.012
  2. Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
    View in: PubMed
    Score: 0.012
  3. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia. Am J Hematol. 2009 Jun; 84(6):328-34.
    View in: PubMed
    Score: 0.010
  4. The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol. 2006 Jul; 134(2):233-7.
    View in: PubMed
    Score: 0.008
  5. Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. Br J Haematol. 2006 Feb; 132(4):523-9.
    View in: PubMed
    Score: 0.008
  6. Soluble transferrin receptor-1 levels in mice do not affect iron absorption. Acta Haematol. 2006; 116(4):249-54.
    View in: PubMed
    Score: 0.008
  7. Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Blood Adv. 2024 11 12; 8(21):5529-5538.
    View in: PubMed
    Score: 0.007
  8. Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic immune dysregulation. Eur J Haematol. 2021 Jun; 106(6):783-787.
    View in: PubMed
    Score: 0.006
  9. Genetic variants in toll-like receptor 4 are associated with lack of steroid-responsiveness in pediatric ITP patients. Am J Hematol. 2020 04; 95(4):395-400.
    View in: PubMed
    Score: 0.005
  10. Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition. Transfusion. 2018 03; 58(3):726-735.
    View in: PubMed
    Score: 0.005
  11. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil. Blood Cells Mol Dis. 2016 11; 62:32-37.
    View in: PubMed
    Score: 0.004
  12. Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia. PLoS One. 2016; 11(10):e0164364.
    View in: PubMed
    Score: 0.004
  13. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol. 2013 Jul; 88(7):571-6.
    View in: PubMed
    Score: 0.003
  14. Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood. 2011 Nov 03; 118(18):4985-91.
    View in: PubMed
    Score: 0.003
  15. Frequency distribution of the Los Angeles and Duarte galactose-1-phosphate uridyltransferase variant alleles in the Irish population. Mol Genet Metab. 2004 Aug; 82(4):345-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.